APO Research
Talk to an analyst

APO RESEARCH · REPORT

Extracorporeal Membrane Oxygenation (ECMO) Service

Extracorporeal Membrane Oxygenation (ECMO) provides extended cardiac and respiratory support to persons whose heart and lungs cannot adequately function to sustain life.ECLS/ECMO support patients facing life-threatening situations, such as heart or lung failure due to illness, after cardiac surgery, or as a bridge for patients awaiting a lung transplant or heart assist device.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Extracorporeal Membrane Oxygenation (ECMO) provides extended cardiac and respiratory support to persons whose heart and lungs cannot adequately function to sustain life.ECLS/ECMO support patients facing life-threatening situations, such as heart or lung failure due to illness, after cardiac surgery, or as a bridge for patients awaiting a lung transplant or heart assist device.

Selected research

Market Outlook & Growth Opportunities

Global Extracorporeal Membrane Oxygenation (ECMO) Service Market Outlook and Growth Opportunities 2026

29 December 2025197 pages

Choose your research edition.

Industry ResearchExtracorporeal Membrane Oxygenation (ECMO) Service Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Extracorporeal Membrane Oxygenation (ECMO) Service Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Extracorporeal Membrane Oxygenation (ECMO) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Extracorporeal Membrane Oxygenation (ECMO) Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Extracorporeal Membrane Oxygenation (ECMO) Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Extracorporeal Membrane Oxygenation (ECMO) provides extended cardiac and respiratory support to persons whose heart and lungs cannot adequately function to sustain life.ECLS/ECMO support patients facing life-threatening situations, such as heart or lung failure due to illness, after cardiac surgery, or as a bridge for patients awaiting a lung transplant or heart assist device.

In North America, the main players of Extracorporeal Membrane Oxygenation (ECMO) Service include Comprehensive Care Services and SpecialtyCare, etc. In terms of application, the service and related products are mainly used by adults, followed by pediatric.

This report provides an overview of the global Extracorporeal Membrane Oxygenation (ECMO) Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Extracorporeal Membrane Oxygenation (ECMO) Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Extracorporeal Membrane Oxygenation (ECMO) Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Extracorporeal Membrane Oxygenation (ECMO) Service market.

Extracorporeal Membrane Oxygenation (ECMO) Service Segment by Company

Comprehensive Care Services

Keystone Perfusion Services

SpecialtyCare

Perfusion Solution

PROCIRCA

Vivacity Perfusion

Memorial

Extracorporeal Membrane Oxygenation (ECMO) Service Segment by Type

VA (Veno-Arterial) ECMO Services

VV (Veno-Venous) ECMO Services

Extracorporeal Membrane Oxygenation (ECMO) Service Segment by Application

Adult

Neonatal

Pediatric

Extracorporeal Membrane Oxygenation (ECMO) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Extracorporeal Membrane Oxygenation (ECMO) Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Extracorporeal Membrane Oxygenation (ECMO) Service key companies, revenue, market share, and recent developments.

3. To split the Extracorporeal Membrane Oxygenation (ECMO) Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Extracorporeal Membrane Oxygenation (ECMO) Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Extracorporeal Membrane Oxygenation (ECMO) Service significant trends, drivers, influence factors in global and regions.

6. To analyze Extracorporeal Membrane Oxygenation (ECMO) Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Extracorporeal Membrane Oxygenation (ECMO) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Extracorporeal Membrane Oxygenation (ECMO) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Extracorporeal Membrane Oxygenation (ECMO) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Extracorporeal Membrane Oxygenation (ECMO) Service industry.

Chapter 3: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Extracorporeal Membrane Oxygenation (ECMO) Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Extracorporeal Membrane Oxygenation (ECMO) Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Extracorporeal Membrane Oxygenation (ECMO) Service Industry Trends Table 2. Extracorporeal Membrane Oxygenation (ECMO) Service Industry Drivers Table 3. Extracorporeal Membrane Oxygenation (ECMO) Service Industry Opportunities and Challenges Table 4. Extracorporeal Membrane Oxygenation (ECMO) Service Industry Restraints Table 5. Global Extracorporeal Membrane Oxygenation (ECMO) Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Extracorporeal Membrane Oxygenation (ECMO) Service Revenue Share by Company (2021-2026) Table 7. Global Extracorporeal Membrane Oxygenation (ECMO) Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Extracorporeal Membrane Oxygenation (ECMO) Service Key Company Manufacturing Base & Headquarters Table 9. Global Extracorporeal Membrane Oxygenation (ECMO) Service Company, Product Type & Application Table 10. Global Extracorporeal Membrane Oxygenation (ECMO) Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Extracorporeal Membrane Oxygenation (ECMO) Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of VA (Veno-Arterial) ECMO Services Table 15. Significant Companies of VV (Veno-Venous) ECMO Services Table 16. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type (2021-2026) Table 20. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Adult Table 22. Significant Companies of Neonatal Table 23. Significant Companies of Pediatric Table 24. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application (2021-2026) Table 28. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application (2027-2032) Table 29. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Region (2021-2026) Table 32. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Region (2027-2032) Table 34. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Market Share by Country (2021-2026) Table 37. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Market Share by Country (2027-2032) Table 39. Comprehensive Care Services Company Information Table 40. Comprehensive Care Services Business Overview Table 41. Comprehensive Care Services Extracorporeal Membrane Oxygenation (ECMO) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Comprehensive Care Services Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio Table 43. Comprehensive Care Services Recent Development Table 44. Keystone Perfusion Services Company Information Table 45. Keystone Perfusion Services Business Overview Table 46. Keystone Perfusion Services Extracorporeal Membrane Oxygenation (ECMO) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Keystone Perfusion Services Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio Table 48. Keystone Perfusion Services Recent Development Table 49. SpecialtyCare Company Information Table 50. SpecialtyCare Business Overview Table 51. SpecialtyCare Extracorporeal Membrane Oxygenation (ECMO) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. SpecialtyCare Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio Table 53. SpecialtyCare Recent Development Table 54. Perfusion Solution Company Information Table 55. Perfusion Solution Business Overview Table 56. Perfusion Solution Extracorporeal Membrane Oxygenation (ECMO) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Perfusion Solution Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio Table 58. Perfusion Solution Recent Development Table 59. PROCIRCA Company Information Table 60. PROCIRCA Business Overview Table 61. PROCIRCA Extracorporeal Membrane Oxygenation (ECMO) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. PROCIRCA Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio Table 63. PROCIRCA Recent Development Table 64. Vivacity Perfusion Company Information Table 65. Vivacity Perfusion Business Overview Table 66. Vivacity Perfusion Extracorporeal Membrane Oxygenation (ECMO) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Vivacity Perfusion Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio Table 68. Vivacity Perfusion Recent Development Table 69. Memorial Company Information Table 70. Memorial Business Overview Table 71. Memorial Extracorporeal Membrane Oxygenation (ECMO) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Memorial Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio Table 73. Memorial Recent Development Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Extracorporeal Membrane Oxygenation (ECMO) Service Product Image Figure 2. Global Extracorporeal Membrane Oxygenation (ECMO) Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Extracorporeal Membrane Oxygenation (ECMO) Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Extracorporeal Membrane Oxygenation (ECMO) Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. VA (Veno-Arterial) ECMO Services Image Figure 8. VV (Veno-Venous) ECMO Services Image Figure 9. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type (2021-2032) Figure 12. Adult Image Figure 13. Neonatal Image Figure 14. Pediatric Image Figure 15. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application (2021-2032) Figure 18. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • VA (Veno-Arterial) ECMO Services
  • VV (Veno-Venous) ECMO Services
Applications
  • Adult
  • Neonatal
  • Pediatric
Companies covered
  • Comprehensive Care Services
  • Keystone Perfusion Services
  • SpecialtyCare
  • Perfusion Solution
  • PROCIRCA
  • Vivacity Perfusion
  • Memorial

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Extracorporeal Membrane Oxygenation (ECMO) Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Extracorporeal Membrane Oxygenation (ECMO) Service Market Dynamics
  1. 2.1 Extracorporeal Membrane Oxygenation (ECMO) Service Industry Trends
  2. 2.2 Extracorporeal Membrane Oxygenation (ECMO) Service Industry Drivers
  3. 2.3 Extracorporeal Membrane Oxygenation (ECMO) Service Industry Opportunities and Challenges
  4. 2.4 Extracorporeal Membrane Oxygenation (ECMO) Service Industry Restraints
3 Extracorporeal Membrane Oxygenation (ECMO) Service Market by Company
  1. 3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Service Company Revenue Ranking in 2025
  2. 3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Revenue by Company (2021-2026)
  3. 3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Service Company Ranking (2024-2026)
  4. 3.4 Global Extracorporeal Membrane Oxygenation (ECMO) Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Extracorporeal Membrane Oxygenation (ECMO) Service Company Product Type and Application
  6. 3.6 Global Extracorporeal Membrane Oxygenation (ECMO) Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Extracorporeal Membrane Oxygenation (ECMO) Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Extracorporeal Membrane Oxygenation (ECMO) Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Extracorporeal Membrane Oxygenation (ECMO) Service Market by Type
  1. 4.1 Extracorporeal Membrane Oxygenation (ECMO) Service Type Introduction
  2. 4.1.1 VA (Veno-Arterial) ECMO Services
  3. 4.1.2 VV (Veno-Venous) ECMO Services
  4. 4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Type
  5. 4.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type (2021-2032)
5 Extracorporeal Membrane Oxygenation (ECMO) Service Market by Application
  1. 5.1 Extracorporeal Membrane Oxygenation (ECMO) Service Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Neonatal
  4. 5.1.3 Pediatric
  5. 5.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Application
  6. 5.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application (2021-2032)
6 Extracorporeal Membrane Oxygenation (ECMO) Service Regional Value Analysis
  1. 6.1 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032)
  7. 6.3.2 North America Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032)
  10. 6.4.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032)
  16. 6.6.2 South America Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Country, 2025 VS 2032
7 Extracorporeal Membrane Oxygenation (ECMO) Service Country-level Value Analysis
  1. 7.1 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Extracorporeal Membrane Oxygenation (ECMO) Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Comprehensive Care Services
  2. 8.1.1 Comprehensive Care Services Company Information
  3. 8.1.2 Comprehensive Care Services Business Overview
  4. 8.1.3 Comprehensive Care Services Extracorporeal Membrane Oxygenation (ECMO) Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Comprehensive Care Services Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio
  6. 8.1.5 Comprehensive Care Services Recent Developments
  7. 8.2 Keystone Perfusion Services
  8. 8.2.1 Keystone Perfusion Services Company Information
  9. 8.2.2 Keystone Perfusion Services Business Overview
  10. 8.2.3 Keystone Perfusion Services Extracorporeal Membrane Oxygenation (ECMO) Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Keystone Perfusion Services Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio
  12. 8.2.5 Keystone Perfusion Services Recent Developments
  13. 8.3 SpecialtyCare
  14. 8.3.1 SpecialtyCare Company Information
  15. 8.3.2 SpecialtyCare Business Overview
  16. 8.3.3 SpecialtyCare Extracorporeal Membrane Oxygenation (ECMO) Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SpecialtyCare Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio
  18. 8.3.5 SpecialtyCare Recent Developments
  19. 8.4 Perfusion Solution
  20. 8.4.1 Perfusion Solution Company Information
  21. 8.4.2 Perfusion Solution Business Overview
  22. 8.4.3 Perfusion Solution Extracorporeal Membrane Oxygenation (ECMO) Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Perfusion Solution Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio
  24. 8.4.5 Perfusion Solution Recent Developments
  25. 8.5 PROCIRCA
  26. 8.5.1 PROCIRCA Company Information
  27. 8.5.2 PROCIRCA Business Overview
  28. 8.5.3 PROCIRCA Extracorporeal Membrane Oxygenation (ECMO) Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PROCIRCA Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio
  30. 8.5.5 PROCIRCA Recent Developments
  31. 8.6 Vivacity Perfusion
  32. 8.6.1 Vivacity Perfusion Company Information
  33. 8.6.2 Vivacity Perfusion Business Overview
  34. 8.6.3 Vivacity Perfusion Extracorporeal Membrane Oxygenation (ECMO) Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vivacity Perfusion Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio
  36. 8.6.5 Vivacity Perfusion Recent Developments
  37. 8.7 Memorial
  38. 8.7.1 Memorial Company Information
  39. 8.7.2 Memorial Business Overview
  40. 8.7.3 Memorial Extracorporeal Membrane Oxygenation (ECMO) Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Memorial Extracorporeal Membrane Oxygenation (ECMO) Service Product Portfolio
  42. 8.7.5 Memorial Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst